Author

Fumitake Saito

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Kei SatoiD· 2 shared Keiya Uriu· 2 shared Yoshifumi UwaminoiD· 2 shared Yu KakuiD· 2 shared Hironori Satoh· 1 shared Hiroshi FujiwaraiD· 1 shared Jumpei ItoiD· 1 shared Maximilian Stanley Yo· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Kei SatoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Humoral immunity induced by LP.8.1 monovalent vaccines against a broad range of SARS-CoV-2 variants including XEC, NB.1.8.1, XFG, and BA.3.2

Yu Kaku, Mizuka Fujiwara, Keiya Uriu, Maximilian Stanley Yo, Shusuke Kawakubo, Jumpei Ito, Naoya Itoh, Yoshifumi Uwamino, Fumitake Saito, Hironori Satoh, Kei Sato

This study evaluates the humoral immune response induced by LP.8.1-based vaccines against multiple SARS-CoV-2 variants, showing effective cross-neutralization and immune boosting.

bioRxiv · Nov 18, 2025 · PreprintMicrobiology

Robust antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against a broad range of SARS-CoV-2 Omicron subvariants including JN.1, KP.3.1.1 and XEC

Keiya Uriu, Yu Kaku, Yoshifumi Uwamino, Hiroshi Fujiwara, Fumitake Saito, Kei Sato

This study compares the antiviral humoral immunity induced by two JN.1 monovalent mRNA vaccines against multiple SARS-CoV-2 Omicron subvariants and XEC, showing both vaccines boost immunity with statistical significance.

The Lancet Infectious Diseases · Dec 10, 2024Peer-reviewedMicrobiology